Cite
APA Citation
Grellety, T., Cousin, S., Letinier, L., Bosco-Lévy, P., Hoppe, S., Joly, D., Penel, N., Mathoulin-Pelissier, S., & Italiano, A. (2016). pRognostic factor of Early Death In phase II Trials or the end of 'sufficient life expectancy' as an inclusion criterion? (PREDIT model). BMC cancer, 16(1), 1–8. http://access.bl.uk/ark:/81055/vdc_100080855450.0x0001b0